Amantadine

Amantadine

Form: Tablet; Capsule; Oral Solution and ER Capsule

Strength: Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg

Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)

Category: Anti Viral

Amantadine is an antiviral and CNS-active medication used for the treatment of Parkinson’s disease, drug-induced extrapyramidal symptoms, and formerly for Influenza A. It acts as an NMDA receptor antagonist and M2 ion channel blocker, helping reduce symptoms of tremor and dyskinesia. Available in 100 mg tablets, capsules, oral solution, and extended-release forms, Amantadine is FDA and EMA approved. Though antiviral use has declined due to resistance, it remains valuable in neurology. Brand names include Symmetrel, Gocovri, and Osmolex ER. Amantadine is widely used in elderly care and neurorehabilitation for its dopaminergic activity and fatigue-reducing effects.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Zanamivir

Strength: 5 mg/blister

Form: Inhalation powder

Reference Brands: Relenza(EU & US)

View Details Get Enquiry
Oseltamivir Phosphate Capsule

Strength: Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)

Form: Capsules and Oral solution

Reference Brands: Tamiflu(EU & US)

View Details Get Enquiry
Glecaprevir + Pibrentasvir

Strength: Glecaprevir- 100 mg + Pibrentasvir - 40 mg

Form: Tablet

Reference Brands: Mavyret (US); Maviret (EU)

View Details Get Enquiry
Velpatasvir + Sofosbuvir

Strength: Sofosbuvir - 400 mg + Velpatasvir - 100 mg

Form: Tablet

Reference Brands: Epclusa(US & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.